These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31543781)

  • 1. Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma.
    Tun Min S; Nordman IIC; Tran HA
    Case Rep Oncol; 2019; 12(2):639-643. PubMed ID: 31543781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
    Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
    D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
    JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
    Kaufman HL; Russell JS; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Milella M; Brownell I; Lewis KD; Lorch JH; von Heydebreck A; Hennessy M; Nghiem P
    J Immunother Cancer; 2018 Jan; 6(1):7. PubMed ID: 29347993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avelumab: A Review in Metastatic Merkel Cell Carcinoma.
    Shirley M
    Target Oncol; 2018 Jun; 13(3):409-416. PubMed ID: 29799096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma.
    Torchio M; Cattaneo L; Milione M; Prinzi N; Corti F; Ungari M; Anichini A; Mortarini R; Occhini A; Bertino G; Maurichi A; Coppa J; Di Bartolomeo M; de Braud FG; Pusceddu S
    Front Oncol; 2021; 11():628324. PubMed ID: 34221958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable Response to Treatment with Avelumab in an HIV-Positive Patient with Advanced Merkel Cell Carcinoma Previously Refractory to Chemotherapy.
    Al Homsi MU; Mostafa M; Fahim K
    Case Rep Oncol; 2018; 11(2):467-475. PubMed ID: 30140209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
    Barkdull S; Brownell I
    Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avelumab for the treatment of metastatic Merkel cell carcinoma.
    Cordes LM; Gulley JL
    Drugs Today (Barc); 2017 Jul; 53(7):377-383. PubMed ID: 28837181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
    Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA
    Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single administration of avelumab induced a complete response in thyroid transcription factor 1-positive combined Merkel cell carcinoma.
    Kanemaru H; Fukushima S; Mizukami Y; Sawamura S; Nakamura K; Honda N; Makino K; Kajihara I; Aoi J; Makino T; Kawasaki T; Kudou E; Jhono M; Ito T; Arima N; Ihn H
    J Dermatol; 2020 Nov; 47(11):1317-1321. PubMed ID: 32794263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in Merkel cell carcinoma: role of Avelumab.
    Palla AR; Doll D
    Immunotargets Ther; 2018; 7():15-19. PubMed ID: 29535979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma.
    Ugolini H; Bryan J; Hennessy M; Kaufman HL; D'Angelo S
    Clin J Oncol Nurs; 2019 Feb; 23(1):E1-E9. PubMed ID: 30682006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PD-L1 Treatment Induced Central Diabetes Insipidus.
    Zhao C; Tella SH; Del Rivero J; Kommalapati A; Ebenuwa I; Gulley J; Strauss J; Brownell I
    J Clin Endocrinol Metab; 2018 Feb; 103(2):365-369. PubMed ID: 29220526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
    Grignani G; Chiarion Sileni V; Pinto C; Depenni R; Fazio N; Galli L; Giuffrida D; Carnaghi C; Ciliberto D; Corsi DC; Queirolo P; Benincasa E; Venturini F; Fazzi G; Costa N; Ascierto PA
    J Transl Med; 2021 Feb; 19(1):70. PubMed ID: 33588870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma.
    Teets A; Pham L; Tran EL; Hochmuth L; Deshmukh R
    Crit Rev Immunol; 2018; 38(3):159-206. PubMed ID: 30004857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
    Rubin KM; Hoffner B; Bullock AC
    Semin Oncol Nurs; 2019 Oct; 35(5):150924. PubMed ID: 31514991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
    Bhanegaonkar A; Liu FX; Boyd M; Fulcher N; Kim R; Krulewicz S; Smith J; Cowey CL
    Oncologist; 2021 Sep; 26(9):e1633-e1643. PubMed ID: 34101298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response with neoadjuvant avelumab in Merkel cell carcinoma - A case report.
    Abdallah N; Nagasaka M; Chowdhury T; Raval K; Hotaling J; Sukari A
    Oral Oncol; 2019 Dec; 99():104350. PubMed ID: 31277904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.